126
Views
19
CrossRef citations to date
0
Altmetric
Original Research

High ACTN1 Is Associated with Poor Prognosis, and ACTN1 Silencing Suppresses Cell Proliferation and Metastasis in Oral Squamous Cell Carcinoma

, , ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 1717-1727 | Published online: 05 May 2020

References

  • RiveraC. Essentials of oral cancer. Int J Clin Exp Pathol. 2015;8(9):11884–11894.26617944
  • ChoiS, MyersJN. Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res. 2008;87(1):14–32. doi:10.1177/15440591080870010418096889
  • ZiniA, CzerninskiR, Sgan-CohenHD. Oral cancer over four decades: epidemiology, trends, histology, and survival by anatomical sites. J Oral Pathol Med. 2010;39(4):299–305. doi:10.1111/j.1600-0714.2009.00845.x20040019
  • de AguiarA, KowalskiLP, de AlmeidaOP. Clinicopathological and immunohistochemical evaluation of oral squamous cell carcinoma in patients with early local recurrence. Oral Oncol. 2007;43(6):593–601. doi:10.1016/j.oraloncology.2006.07.00317070093
  • FoleyKS, YoungPW. The non-muscle functions of actinins: an update. Biochem J. 2014;459(1):1–13. doi:10.1042/BJ2013151124627985
  • ShaoH, WangJH, PollakMR, WellsA. α-actinin-4 is essential for maintaining the spreading, motility and contractility of fibroblasts. PLoS One. 2010;5(11):e13921. doi:10.1371/journal.pone.001392121085685
  • TentlerD, LomertE, NovitskayaK, BarlevNA. Role of ACTN4 in tumorigenesis, metastasis, and EMT. Cells. 2019;8(11):E1427. doi:10.3390/cells811142731766144
  • KakuyaT, MoriT, YoshimotoS, et al. Prognostic significance of gene amplification of ACTN4 in stage I and II oral tongue cancer. Int J Oral Maxillofac Surg. 2017;46(8):968–976. doi:10.1016/j.ijom.2017.03.00128385383
  • LiuX, ChuK-M. α-Actinin-4 promotes metastasis in gastric cancer. Lab Invest. 2017;97(9):1084–1094. doi:10.1038/labinvest.2017.2828581489
  • YangX, PangY, ZhangJ, et al. High expression levels of ACTN1 and ACTN3 indicate unfavorable prognosis in acute myeloid leukemia. J Cancer. 2019;10(18):4286–4292. doi:10.7150/jca.3176631413748
  • TangZ, LiC, KangB, GaoG, LiC, ZhangZ. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx24728407145
  • XuJ, LvH, ZhangB, et al. miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma. J Thorac Dis. 2019;11(7):3015–3029. doi:10.21037/jtd.2019.07.5031463131
  • McGowanCH. Regulation of the eukaryotic cell cycle. Prog Cell Cycle Res. 2003;5:1–4.14593695
  • PistrittoG, TrisciuoglioD, CeciC, GarufiA, D’OraziG. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging. 2016;8(4):603–619. doi:10.18632/aging.10093427019364
  • ElmoreS. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007;35(4):495–516. doi:10.1080/0192623070132033717562483
  • GoldarS, KhanianiMS, DerakhshanSM, BaradaranB. Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pac J Cancer Prev. 2015;16(6):2129–2144. doi:10.7314/APJCP.2015.16.6.212925824729
  • LamouilleS, XuJ, DerynckR. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178–196.24556840
  • YeungKT, YangJ. Epithelial-mesenchymal transition in tumor metastasis. Mol Oncol. 2017;11(1):28–39. doi:10.1002/1878-0261.1201728085222
  • DiepenbruckM, ChristoforiG. Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe? Curr Opin Cell Biol. 2016;43:7–13. doi:10.1016/j.ceb.2016.06.00227371787
  • LiaoTT, YangMH. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness. Mol Oncol. 2017;11(7):792–804. doi:10.1002/1878-0261.1209628649800